Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium

J Oncol Pharm Pract. 2016 Dec;22(6):766-770. doi: 10.1177/1078155215610915. Epub 2015 Oct 6.

Abstract

Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden of drug shortages of chemotherapeutics in the paediatric hemato-oncology unit of a tertiary care hospital and solutions that were used to manage them. Between January 2001 and December 2014, 54 individual shortages were detected, affecting a total number of 21 different drugs. In total, 4127 shortage days were registered with a mean duration of 196.5 SD ± 144.0 days per individual drug shortage. Methotrexate, doxorubicin and carboplatin had the longest supply disruptions. Solutions to address the problems were purchase of a generic alternative, a change of individual treatment plans, cohorting of patients and import from abroad.

Keywords: Drug shortages; oncology; paediatrics.

MeSH terms

  • Antineoplastic Agents / supply & distribution*
  • Antineoplastic Agents / therapeutic use
  • Belgium / epidemiology
  • Child
  • Drugs, Generic / supply & distribution
  • Drugs, Generic / therapeutic use
  • Humans
  • Medical Oncology* / methods
  • Neoplasms / drug therapy
  • Neoplasms / epidemiology
  • Pediatrics* / methods
  • Tertiary Care Centers / supply & distribution*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Drugs, Generic